Daniela Femia

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm.

Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm.

Journal: Scandinavian journal of gastroenterology

Published: August 28, 2019

Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations.

Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: March 14, 2019

Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.

Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.

Journal: Targeted oncology

Published: August 04, 2018

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors.

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors.

Journal: Endocrine-related cancer

Published: March 15, 2018

Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study.

Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: October 24, 2017

Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors.

Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors.

Journal: Future oncology (London, England)

Published: June 06, 2017

Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.

Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.

Journal: Therapeutic advances in medical oncology

Published: March 28, 2017

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.

Journal: Gastroenterology

Published: March 06, 2017

Update on medical treatment of small intestinal neuroendocrine tumors.

Update on medical treatment of small intestinal neuroendocrine tumors.

Journal: Expert review of anticancer therapy

Published: June 30, 2016

Primary Cerebellar Neuroendocrine Tumors: Chimeras or Real Entities? A Case Report with a 6-Year Follow-Up.

Primary Cerebellar Neuroendocrine Tumors: Chimeras or Real Entities? A Case Report with a 6-Year Follow-Up.

Journal: Case reports in oncology

Published: June 22, 2016

Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes.

Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes.

Journal: Future oncology (London, England)

Published: February 19, 2016

How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies.

How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies.

Journal: Oncotarget

Published: December 14, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026